Table 1.
Regions of interest (radius 6 mm) | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sequencing | Mentalizing | Sequencing | ||||||||||||
ROI 1 | ROI 2 | ROI 3 | ROI 4 | ROI 5 | ||||||||||
Right Crus II | Left Crus II | Right Crus II | Left Crus II | Left Crus I | ||||||||||
24 −76 −40 | −24 −76 −40 | 26 −84 −34 | −26 −84 −34 | −40 −70 −40 | Studies | % | ||||||||
Excluded studies | ||||||||||||||
Criteria for exclusion: | ||||||||||||||
Technique and analysis | ||||||||||||||
Volume | 3 | 1 | 4 | 3 | 3 | 14 | 3% | |||||||
Connectivity | 7 | 2 | 10 | 8 | 4 | 31 | 7% | |||||||
Resting state | 2 | 4 | 9 | 2 | 7 | 24 | 6% | |||||||
Meta-analysis | 0 | 0 | 1 | 1 | 2 | 4 | 1% | |||||||
Other (SPECT, EEG, etc.) | 0 | 1 | 1 | 3 | 3 | 8 | 2% | |||||||
Population and non-psychological factors | ||||||||||||||
Patients | 7 | 13 | 9 | 10 | 12 | 61 | 14% | |||||||
Medication/substance | 0 | 0 | 1 | 1 | 1 | 3 | 1% | |||||||
Genetic interaction | 1 | 0 | 1 | 0 | 0 | 2 | 0% | |||||||
Coordinates | ||||||||||||||
Incorrect coordinates | 1 | 1 | 2 | 0 | 1 | 5 | 1% | |||||||
Talairach coordinates | 11 | 8 | 19 | 8 | 9 | 55 | 13% | |||||||
Other | ||||||||||||||
1 | 2 | 3 | 1 | 1 | 8 | 2% | ||||||||
Number of excluded studies | 33 | 32 | 60 | 37 | 43 | 215 | 51% | |||||||
% of excluded studies | 40% | 52% | 52% | 49% | 56% | |||||||||
Included studies | ||||||||||||||
Demographics (means): | ||||||||||||||
Number of participants | 23.0 | 45.6 | 40.6 | 45.3 | 20.2 | |||||||||
Males | 12.2 | 20.1 | 18.1 | 22.1 | 11.8 | |||||||||
Mean age | 28.2 | 27.3 | 26.6 | 25.7 | 25.2 | |||||||||
Number of included studies | 48 | 30 | 56 | 39 | 34 | 207 | 49% |
A chi-square test revealed that none of the ROIs showed an unequal distribution of the exclusion criteria, P > 0.08. SPECT = Single Photon Emission Computed Tomography; EEG = Electro-encefalography